Smith, Head of Business Development, Douglas CDMO, touts the advantages of and dispels misconceptions about mid-sized CDMOs.

Galapagos, a global biotechnology company, has appointed the founding CEO of its new subsidiary & announced the search for a ...

Repertoire Immune Medicines has entered into a collaboration and license agreement with Genentech to discover and develop innovative T cell-targeted immune medicines.

Singh will lead the discovery and clinical translation of peptide medicines, investing in new technologies, including data and computational science.

Antag Therapeutics, a biopharmaceutical company pioneering novel treatments for obesity, has appointed three new hires to support the Company’s next phase of growth following the recent initiation of ...

Join Mike O’Mara, COO of Cellipont Bioservices, and Marcia Blackmoore, VP of Customer Operations at L7 Informatics, for a ...

Board Certified in Endocrinology, Diabetes, and Metabolism and Internal Medicine, Dr. Caveney leads IQVIA’s Obesity, ...

Suanfarma, a global company specializing in the development, production, and commercialization of active pharmaceutical ingredients (APIs) and high-value CDMO services for the health industry, has ...

Andrei Georgescu of Vivodyne discusses key advantages of its humanized drug testing platform and the impact of the FDA’s ...

Carbogen Amcis’ Shanghai facility has successfully obtained its first Drug Manufacturing License (DML) from China’s NMPA.

The company has expanded its laboratories in the Virginia Biotechnology Research Park in Richmond, Virginia, by acquiring additional analytical capabilities, including advanced spectroscopy tools and ...

The agreement is valued at over $3 billion and increases U.S. manufacturing capacity to help ensure patient access to ...